Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Stock Symbol
-
BBIO on Nasdaq
KKR Genetic Disorder L.P. - trading volume in the past year for BridgeBio Pharma, Inc.
Holdings reported by KKR Genetic Disorder L.P. for BridgeBio Pharma, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
25.3M |
$650M |
$25.75 |
Sep 13, 2024 |
Indirect |
|
|
Transactions reported by KKR Genetic Disorder L.P. for BridgeBio Pharma, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.